CD274 and neoplasm: Not only is the effective response rate to monotherapy low (18, 19), but there is insufficient knowledge of predictive biomarkers of ICI treatment response such as programmed death ligand 1 (PD-L1) expression, tumor mutational burden (TMB), and microsatellite instability (MSI) status (20, 21).